Home Immunology & Inflammation gp120/CD4

gp120/CD4

gp120/CD4 Products

  • All (4)
  • gp120/CD4 Inhibitors (3)
  • gp120/CD4 Antibodie (1)
  • New gp120/CD4 Products
Catalog No. Product Name Information Product Use Citations Product Validations
A2101 Anti-mouse CD4-InVivo Anti-mouse CD4 antibody(Clone: GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.
Cell Rep, 2024, 43(6):114300
Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00959-1
Sci Adv, 2024, 10(34):eadp8647
S2632 BMS-378806 BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.
Commun Biol, 2023, 6(1):535
J Virol, 2021, 95(24):e0052921
J Virol, 2020, 10.1128/JVI.00148-20
S7220 Fostemsavir Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
S7487 YYA-021 YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.
S2632 BMS-378806 BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.
Commun Biol, 2023, 6(1):535
J Virol, 2021, 95(24):e0052921
J Virol, 2020, 10.1128/JVI.00148-20
S7220 Fostemsavir Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
S7487 YYA-021 YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.
A2101 Anti-mouse CD4-InVivo Anti-mouse CD4 antibody(Clone: GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.
Cell Rep, 2024, 43(6):114300
Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00959-1
Sci Adv, 2024, 10(34):eadp8647

Choose Selective gp120/CD4 Inhibitors

Tags: gp120/CD4 inhibitor|gp120/CD4 agonist|gp120/CD4 activator|gp120/CD4 inducer|gp120/CD4 antagonist|gp120/CD4 signaling pathway|gp120/CD4 assay kit